Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
Phase Ib Study of Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Background: Runt-related transcription factor 1 (RUNX1) gene regulates the formation of blood cells. People with mutations of this gene may bleed or bruise ea…
Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT06090669
Phase 1
Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
To evaluate the safety and feasibility of collecting hematopoietic stem cells (HSC) in participants with RUNX1-FPD.
RUNX1 Familial Platelet Disorder
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06414889
ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People With Non-Neoplastic Hematologic Disorders
In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently F…
Hematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more
Estimated
~$10 – $1,125
American Thrombosis and Hemostasis NetworkNCT04398628